# Goal-directed Fluid Therapy During Deep Inferior Epigastric Perforator (DIEP) Free Flap Breast Reconstruction

> **NCT06080178** · PHASE4 · RECRUITING · sponsor: **Algemeen Ziekenhuis Maria Middelares** · enrollment: 82 (estimated)

## Conditions studied

- Hypotension During Surgery

## Interventions

- **DRUG:** Plasma-lyte (static group)
- **DRUG:** Norepinephrine (static group)
- **DRUG:** Plasma-lyte (dynamic group)
- **DRUG:** Norepinephrine (dynamic group)

## Key facts

- **NCT ID:** NCT06080178
- **Lead sponsor:** Algemeen Ziekenhuis Maria Middelares
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-23
- **Primary completion:** 2026-10-01
- **Final completion:** 2026-10-01
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2025-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06080178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06080178, "Goal-directed Fluid Therapy During Deep Inferior Epigastric Perforator (DIEP) Free Flap Breast Reconstruction". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06080178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*